SG10201605001SA - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SG10201605001SA SG10201605001SA SG10201605001SA SG10201605001SA SG10201605001SA SG 10201605001S A SG10201605001S A SG 10201605001SA SG 10201605001S A SG10201605001S A SG 10201605001SA SG 10201605001S A SG10201605001S A SG 10201605001SA SG 10201605001S A SG10201605001S A SG 10201605001SA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0409703.6A GB0409703D0 (en) | 2004-04-30 | 2004-04-30 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201605001SA true SG10201605001SA (en) | 2016-08-30 |
Family
ID=32408337
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201605001SA SG10201605001SA (en) | 2004-04-30 | 2005-04-29 | Pharmaceutical compositions |
| SG2012093886A SG186673A1 (en) | 2004-04-30 | 2005-04-29 | Pharmaceutical compositions |
| SG200903001-6A SG152292A1 (en) | 2004-04-30 | 2005-04-29 | Pharmaceutical compositions |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012093886A SG186673A1 (en) | 2004-04-30 | 2005-04-29 | Pharmaceutical compositions |
| SG200903001-6A SG152292A1 (en) | 2004-04-30 | 2005-04-29 | Pharmaceutical compositions |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20080063719A1 (fr) |
| EP (3) | EP2422767A3 (fr) |
| JP (2) | JP5000483B2 (fr) |
| KR (1) | KR101287919B1 (fr) |
| CN (3) | CN1964700A (fr) |
| AU (2) | AU2005237266B2 (fr) |
| BR (1) | BRPI0510500B8 (fr) |
| CA (1) | CA2563760C (fr) |
| CY (6) | CY1113069T1 (fr) |
| DK (2) | DK2422766T3 (fr) |
| ES (2) | ES2546982T3 (fr) |
| GB (1) | GB0409703D0 (fr) |
| HK (2) | HK1095282A1 (fr) |
| HU (4) | HUE025463T2 (fr) |
| IL (2) | IL178651A (fr) |
| LT (1) | LTC2422766I2 (fr) |
| LU (2) | LU92176I2 (fr) |
| MX (2) | MXPA06012493A (fr) |
| NO (1) | NO20065502L (fr) |
| NZ (1) | NZ550479A (fr) |
| PL (2) | PL1755555T3 (fr) |
| PT (2) | PT1755555E (fr) |
| RU (1) | RU2396943C2 (fr) |
| SG (3) | SG10201605001SA (fr) |
| SI (2) | SI2422766T1 (fr) |
| WO (1) | WO2005105043A2 (fr) |
| ZA (1) | ZA200609350B (fr) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
| GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0525254D0 (en) * | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| GB0622818D0 (en) * | 2006-11-15 | 2006-12-27 | Jagotec Ag | Improvements in or relating to organic compounds |
| KR20100095587A (ko) * | 2007-12-13 | 2010-08-31 | 노파르티스 아게 | 유기 화합물 |
| BRPI0821186A2 (pt) * | 2007-12-13 | 2015-06-16 | Novartis Ag | Compostos orgânicos |
| AU2009241628A1 (en) * | 2008-02-26 | 2009-11-05 | Elevation Pharmaceuticals, Inc. | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| US20100055045A1 (en) | 2008-02-26 | 2010-03-04 | William Gerhart | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| PT3578169T (pt) | 2009-02-26 | 2024-07-29 | Glaxo Group Ltd | Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol |
| CA2759041A1 (fr) * | 2009-04-24 | 2010-10-28 | Schering Corporation | Preparations d'agglomerat utiles dans des inhalateurs a poudre seche |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| GB0921481D0 (en) | 2009-12-08 | 2010-01-20 | Vectura Ltd | Process and product |
| EP2552414A4 (fr) * | 2010-03-31 | 2014-05-14 | Glenmark Pharmaceuticals Ltd | Composition de poudre pharmaceutique pour inhalation |
| TR201811349T4 (tr) | 2010-04-01 | 2018-09-21 | Chiesi Farm Spa | İnhalasyon i̇çi̇n kuru toz taşiyici parti̇külleri̇n hazirlanmasi i̇çi̇n proses. |
| NO2560611T3 (fr) * | 2010-04-21 | 2018-06-02 | ||
| JP5792308B2 (ja) | 2010-08-31 | 2015-10-07 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 水分制御特性を示す乾燥粉末吸入薬物製品及びその投与方法 |
| JP5792307B2 (ja) | 2010-08-31 | 2015-10-07 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 水分制御特性を示す乾燥粉末吸入薬物製品及びその投与方法 |
| JO3510B1 (ar) | 2011-03-04 | 2020-07-05 | Heptares Therapeutics Ltd | استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب |
| EP2836204B1 (fr) | 2012-04-13 | 2020-07-08 | GlaxoSmithKline Intellectual Property Development Limited | Particules agrégées |
| AU2013100007B4 (en) * | 2013-01-04 | 2013-05-23 | Novartis Ag | System for treating chronic obstructive pulmonary disease |
| KR20150119468A (ko) | 2013-02-28 | 2015-10-23 | 더미라, 인코포레이티드 | 글리코피롤레이트 염 |
| US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
| US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
| WO2014144894A1 (fr) * | 2013-03-15 | 2014-09-18 | Pearl Therapeutics, Inc. | Procedes et systemes de conditionnement de matieres cristallines particulaires |
| GB201305825D0 (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
| US9393202B2 (en) * | 2013-04-26 | 2016-07-19 | Chiesi Farmaceutici S.P.A | Particle size reduction of an antimuscarinic compound |
| GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
| MY181647A (en) * | 2014-09-09 | 2020-12-30 | Vectura Ltd | Formulation comprising glycopyrrolate, method and apparatus |
| KR20170068571A (ko) * | 2014-10-16 | 2017-06-19 | 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 | 건조 분말 제제 |
| US9925168B2 (en) * | 2016-01-22 | 2018-03-27 | Chiesi Farmaceutici S.P.A. | Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation |
| RU2713203C1 (ru) | 2016-03-08 | 2020-02-04 | Мерео Байофарма 1 Лимитед | Режим дозирования при лечении острых обострений хронической обструктивной болезни легких |
| JP6741773B2 (ja) | 2016-03-08 | 2020-08-19 | メレオ バイオファーマ １ リミテッド | 炎症状態の急性増悪の治療のための投与レジメン |
| ES2805434T3 (es) | 2016-07-29 | 2021-02-12 | Inke Sa | Procedimiento de estabilización de tamaño de partícula |
| ES2957459T3 (es) | 2016-09-19 | 2024-01-19 | Mexichem Fluor Sa De Cv | Composición farmacéutica que comprende glicopirrolato |
| EP3595631A1 (fr) * | 2017-03-15 | 2020-01-22 | Vectura Limited | Procédé et formulation |
| WO2019060595A1 (fr) | 2017-09-20 | 2019-03-28 | Teva Branded Pharmaceutical Products R&D, Inc. | Médicament inhalable en poudre sèche comprenant du glycopyrronium |
| WO2019060604A1 (fr) * | 2017-09-20 | 2019-03-28 | Teva Branded Pharmaceutical Products R&D, Inc. | Médicament inhalable |
| JP7280627B2 (ja) | 2017-12-11 | 2023-05-24 | メレオ バイオファーマ １ リミテッド | 慢性閉塞性肺疾患の急性増悪の処置における３－［５－アミノ－４－（３－シアノベンゾイル）－ピラゾール－１－イル］－ｎ－シクロプロピル－４－メチルベンズアミドの使用 |
| ES2882978T3 (es) | 2017-12-11 | 2021-12-03 | Mereo Biopharma 1 Ltd | Uso de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciclopropil-4-metilbenzamida en la prevención de exacerbaciones agudas de la enfermedad de obstrucción pulmonar crónica |
| KR102696616B1 (ko) | 2018-12-21 | 2024-08-20 | 한미약품 주식회사 | 흡입 제형용 건조 분말 및 이의 제조방법 |
| WO2023117985A1 (fr) | 2021-12-21 | 2023-06-29 | Chiesi Farmaceutici S.P.A. | Formulations de poudre sèche remplies dans un inhalateur présentant une résistance à l'humidité améliorée |
| CN118414147A (zh) | 2021-12-21 | 2024-07-30 | 凯西制药公司 | 填充在具有改善的耐湿性的吸入器中的干粉制剂 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2956062A (en) * | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
| US3709039A (en) * | 1970-08-31 | 1973-01-09 | Gen Time Corp | Comfort humidity indicator |
| SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
| GB9808470D0 (en) | 1998-04-22 | 1998-06-17 | Smithkline Beecham Plc | Novel process and apparatus |
| CZ303154B6 (cs) | 1998-11-13 | 2012-05-09 | Jagotec Ag | Suchá prášková formulace k inhalaci obsahující stearát horecnatý |
| GB9826284D0 (en) | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
| GB9826286D0 (en) | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
| GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| EP1913939B1 (fr) | 2000-06-27 | 2017-05-31 | Vectura Limited | Formulations destinées à être utilisées dans des dispositifs d'inhalation |
| WO2002043702A2 (fr) * | 2000-11-30 | 2002-06-06 | Vectura Limited | Compositions pharmaceutiques pour inhalation |
| ATE517607T1 (de) * | 2000-11-30 | 2011-08-15 | Vectura Ltd | Verfahren zur herstellung von partikeln zur verwendung in einer pharmazeutischen zusammensetzung |
| RU2294737C2 (ru) * | 2001-03-30 | 2007-03-10 | Яготек Аг | Медицинские аэрозольные составы |
| US20040025876A1 (en) * | 2002-05-07 | 2004-02-12 | Danforth Miller | Capsules for dry powder inhalers and methods of making and using same |
| GB2405798A (en) * | 2003-09-15 | 2005-03-16 | Vectura Ltd | Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device. |
| GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
| EP1861361A1 (fr) * | 2005-03-24 | 2007-12-05 | Sosei R&D Ltd. | Sels de glycopyrronium et leur application thérapeutique |
-
2004
- 2004-04-30 GB GBGB0409703.6A patent/GB0409703D0/en not_active Ceased
-
2005
- 2005-04-29 US US11/587,725 patent/US20080063719A1/en not_active Abandoned
- 2005-04-29 PT PT05738040T patent/PT1755555E/pt unknown
- 2005-04-29 CN CNA200580013592XA patent/CN1964700A/zh active Pending
- 2005-04-29 PT PT111906376T patent/PT2422766E/pt unknown
- 2005-04-29 BR BRPI0510500A patent/BRPI0510500B8/pt active IP Right Grant
- 2005-04-29 KR KR1020067024763A patent/KR101287919B1/ko active IP Right Grant
- 2005-04-29 MX MXPA06012493A patent/MXPA06012493A/es active IP Right Grant
- 2005-04-29 EP EP11190638A patent/EP2422767A3/fr not_active Withdrawn
- 2005-04-29 SG SG10201605001SA patent/SG10201605001SA/en unknown
- 2005-04-29 EP EP05738040A patent/EP1755555B1/fr not_active Revoked
- 2005-04-29 ES ES11190637.6T patent/ES2546982T3/es active Active
- 2005-04-29 HU HUE11190637A patent/HUE025463T2/en unknown
- 2005-04-29 EP EP11190637.6A patent/EP2422766B1/fr not_active Revoked
- 2005-04-29 ES ES05738040T patent/ES2388289T3/es active Active
- 2005-04-29 SI SI200531999T patent/SI2422766T1/sl unknown
- 2005-04-29 PL PL05738040T patent/PL1755555T3/pl unknown
- 2005-04-29 DK DK11190637.6T patent/DK2422766T3/da active
- 2005-04-29 PL PL11190637T patent/PL2422766T3/pl unknown
- 2005-04-29 CN CN201710357916.6A patent/CN107252423A/zh active Pending
- 2005-04-29 SG SG2012093886A patent/SG186673A1/en unknown
- 2005-04-29 NZ NZ550479A patent/NZ550479A/en unknown
- 2005-04-29 SI SI200531570T patent/SI1755555T1/sl unknown
- 2005-04-29 SG SG200903001-6A patent/SG152292A1/en unknown
- 2005-04-29 CA CA2563760A patent/CA2563760C/fr active Active
- 2005-04-29 WO PCT/EP2005/051980 patent/WO2005105043A2/fr active Application Filing
- 2005-04-29 JP JP2007510045A patent/JP5000483B2/ja active Active
- 2005-04-29 RU RU2006142322/15A patent/RU2396943C2/ru active Protection Beyond IP Right Term
- 2005-04-29 AU AU2005237266A patent/AU2005237266B2/en active Active
- 2005-04-29 CN CN2010105642463A patent/CN102008453A/zh active Pending
- 2005-04-29 DK DK05738040.4T patent/DK1755555T3/da active
-
2006
- 2006-10-16 IL IL178651A patent/IL178651A/en active IP Right Review Request
- 2006-10-27 MX MX2012008068A patent/MX341426B/es unknown
- 2006-11-10 ZA ZA2006/09350A patent/ZA200609350B/en unknown
- 2006-11-29 NO NO20065502A patent/NO20065502L/no not_active Application Discontinuation
-
2007
- 2007-02-23 HK HK07102081.9A patent/HK1095282A1/xx not_active IP Right Cessation
-
2011
- 2011-02-09 AU AU2011200543A patent/AU2011200543B2/en active Active
- 2011-11-08 JP JP2011244443A patent/JP5124718B2/ja active Active
-
2012
- 2012-08-13 CY CY20121100722T patent/CY1113069T1/el unknown
- 2012-08-16 HK HK12108085.5A patent/HK1167334A1/xx not_active IP Right Cessation
- 2012-12-10 IL IL223545A patent/IL223545A/en active IP Right Grant
-
2013
- 2013-03-13 HU HUS1300006C patent/HUS1300006I1/hu unknown
- 2013-03-27 LU LU92176C patent/LU92176I2/fr unknown
- 2013-03-29 CY CY2013012C patent/CY2013012I1/el unknown
-
2014
- 2014-03-07 LU LU92392C patent/LU92392I2/fr unknown
- 2014-03-19 CY CY2014015C patent/CY2014015I1/el unknown
-
2015
- 2015-08-27 CY CY20151100754T patent/CY1116655T1/el unknown
- 2015-12-18 LT LTPA2015053C patent/LTC2422766I2/lt unknown
- 2015-12-21 HU HUS1500073C patent/HUS1500073I1/hu unknown
- 2015-12-21 HU HUS1500072C patent/HUS1500072I1/hu unknown
- 2015-12-23 CY CY2015060C patent/CY2015060I1/el unknown
- 2015-12-23 CY CY2015059C patent/CY2015059I1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL223545A0 (en) | Pharmaceutical compositions | |
| ZA200700030B (en) | Pharmaceutical compositions | |
| GB0408308D0 (en) | Pharmaceutical compositions | |
| IL177480A0 (en) | Pharmaceutical composition | |
| PL1837019T3 (pl) | Kompozycja farmaceutyczna rozpadająca się w ustach | |
| IL188352A0 (en) | Pharmaceutical compositions | |
| ZA200804103B (en) | Pharmaceutical compositions | |
| GB0405033D0 (en) | Novel pharmaceutical compositions | |
| GB0406378D0 (en) | Novel pharmaceutical compositions | |
| EP1805154A4 (fr) | Compositions pharmaceutiques | |
| GB0522045D0 (en) | Pharmaceutical compositions | |
| IL192091A0 (en) | Pharmaceutical compositions | |
| GB0406380D0 (en) | Novel pharmaceutical compositions | |
| HU0401177D0 (en) | Pharmaceutical composition | |
| GB2411355B (en) | Pharmaceutical composition | |
| ZA200701932B (en) | Pharmaceutical composition | |
| GB0425255D0 (en) | Pharmaceutical composition | |
| EP1845944A4 (fr) | Compositions pharmaceutiques | |
| ZA200701931B (en) | Pharmaceutical composition | |
| EP1747205A4 (fr) | Compositions pharmaceutiques | |
| GB0502792D0 (en) | Pharmaceutical compositions | |
| ZA200803566B (en) | Pharmaceutical compositions | |
| HUP0401176A2 (en) | Pharmaceutical composition having prpkinetic effect | |
| GB0514259D0 (en) | Pharmaceutical compositions | |
| GB0407351D0 (en) | Pharmaceutical compositions |